GUANETHIDINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Guanethidine, and when can generic versions of Guanethidine launch?
Guanethidine is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in GUANETHIDINE is guanethidine monosulfate. There are two drug master file entries for this compound. Additional details are available on the guanethidine monosulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GUANETHIDINE?
- What are the global sales for GUANETHIDINE?
- What is Average Wholesale Price for GUANETHIDINE?
Summary for GUANETHIDINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | GUANETHIDINE at DailyMed |
US Patents and Regulatory Information for GUANETHIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | GUANETHIDINE MONOSULFATE | guanethidine monosulfate | TABLET;ORAL | 086113-001 | Mar 26, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | GUANETHIDINE MONOSULFATE | guanethidine monosulfate | TABLET;ORAL | 086114-001 | Mar 26, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

